Stanford Medicine Partners with AstraZeneca

The Stanford Center for Clincal Research (SCCR), lead by Dr. Kenneth Mahaffey, MD, and AstraZeneca have entered into a collaboration intended to address major health care challenges.

This collaboration focuses on cardio-metabolic and respiratory diseases, oncology, mobile health (mHealth), innovations in clinical trial design and operations, and education and training initiatives.  Two million dollars in funding will be provided to support innovative research projects of Stanford investigators over the next three years.

The collaboration committee has recently awarded  first two research projects for funding in Year 1 (2016-2017) under this collaboration:

1. "Smartphone guided cardiac rehabilitation and medication adherence management after acute coronary syndrome", PI Dr. Mintu Turakhia, MD
2. "Learning Personalized Treatment Guidelines", PI Dr. Nigam Shah, PhD

As a part of this award, the collaboration will provide a funding of $260,000 to each of these selected projects for the project duration of one year.

The collaboration is excited to announce that it will start accepting the next round of research proposal applications for Year 2 starting November, 2016. Please contact Nicole Ventre at nventre@stanford.edu for any questions about this collaboration and the proposal submission process and timeline.